Notable Launches The ANSWer Study: An Observational Clinical Trial for Patients with Blood Cancer and Enrolls First Patients
22 janv. 2020 09h14 HE
|
Notable Labs
SAN FRANCISCO, Jan. 22, 2020 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment with a clinically validated platform that rapidly advances drug development, is currently enrolling...
Notable Named To Fast Company’s Inaugural List Of The 50 Best Workplaces for Innovators
05 août 2019 10h45 HE
|
Notable Labs
SAN FRANCISCO, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment with a clinically validated platform that rapidly advances cancer drug development at a fraction of the...
Notable Announces $40M Series B Round to Fuel Development of Its Drug Discovery Platform for Personalized Oncology
16 juil. 2019 07h00 HE
|
Notable Labs
SAN FRANCISCO, July 16, 2019 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment with a clinically validated platform that rapidly advances cancer drug development at a fraction of the...
In Personalized Medicine Feasibility Study, Stanford Medical Center, With Partners Notable and Tempus, Able to Make Rapid Personalized Treatment Recommendations for 100 Percent of Blood Cancer Patients
15 avr. 2019 13h38 HE
|
Notable Labs
SAN FRANCISCO, April 15, 2019 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment with a clinically validated AI platform that rapidly advances cancer drug development at a fraction of...
Oncology Startup Notable Expands Leadership Team With New Chief Medical and Chief Development Officers
25 févr. 2019 11h00 HE
|
Notable Labs
FOSTER CITY, Calif., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment with a clinically validated platform that rapidly advances cancer drug development at a fraction...
Oncology Startup Notable Labs Donates its First Pediatric Therapy to Repurposing Non-Profit
22 janv. 2019 10h00 HE
|
Notable Labs
FOSTER CITY, Calif., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Notable Labs, a startup that accelerates drug development by matching drugs with patients who are most likely to respond, announced today that...